Skip to content
AwardedSVNGoodsFramework agreement€914,400

NAKUP CEPIVA PROTI DAVICI, TETANUSU, OSLOVSKEM KAŠLJU IN OTROŠKI PARALIZI

Published
Published 5 March 2026
Deadline
Closed 9 April 2026

Overview

The National Institute of Public Health procured vaccines against diphtheria, tetanus, pertussis, and poliomyelitis. The contract was awarded to Swixx Biopharma, trgovsko podjetje, d.o.o. for 432,000 EUR on 25 May 2026.

Key details

Country
SVN
Status
Awarded
Category
Goods
Estimated value
€914,400
Procedure
Open
Contract type
Framework agreement
SME suitable
No
Published
5 March 2026
Deadline
Closed
Classification (CPV)
General anti-infectives for systemic use and vaccines

Award outcome

Awarded value
€432,000
Award date
25 May 2026
Contract period
9 April 2026 → 31 December 2027
Winner
  • Swixx Biopharma, trgovsko podjetje, d.o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 June 2026

  2. Contract Notice

    5 March 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: NAKUP CEPIVA PROTI DAVICI, TETANUSU, OSLOVSKEM KAŠLJU IN OTROŠKI PARALIZI — won by Swixx Biopharma, trgovsko podjetje, d.o.o. — Skim